Almorexant in Primary Insomnia

PHASE1CompletedINTERVENTIONAL
Enrollment

161

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

September 30, 2007

Conditions
InsomniaPrimary Insomnia
Interventions
DRUG

almorexant

1 dose of 400 mg in two treatment sequences

DRUG

almorexant

1 dose of 200 mg in two treatment sequences

DRUG

almorexant

1 dose of 100 mg in two treatment sequences

DRUG

almorexant

1 dose of 50 mg mg in two treatment sequences

DRUG

almorexant

1 dose of 1000 mg in two treatment sequences

Trial Locations (27)

Unknown

Medical University of Innsbruck, Dept. of Neurology Sleep Disorder Unit, Innsbruck

Medical University of Vienna, Clinic of Neurology, Vienna

Medical University of Vienna, University Clinic of Psychiatrie, Vienna

The Siesta Group, Vienna

Scan Sleep, Copenhagen

Glostrup University Hospital Department of Sleep Medicine, Glostrup Municipality

Skogby Sleep Clinic, Espoo

Sleep Research Unit, Dentalia, University of Turku, Turku

Charite Campus Benjamin Franklin, Klinik und Hochschulambulanz fur Psychiatrie and Psychotherapie, Berlin

Department of Internal Medicine, Center for Sleep Medicine, Berlin

St Hedwig-Krankenhaus, Akademisches Lehrkrankenhaus der Charite, Berlin

Department of Psychiatry and Psychotherapy of the University Hospital of Freiburg, Freiburg im Breisgau

St. Valentinushaus Klinik fur Psychiatrie und Psychotherapie, Kiedrich

Universitatsklinikum Giessen und Marburg, Standort Marburg, Nervenklinik, Marburg

Klinik und Poliklinik fur Psychiatrie, Psychosomatik und Psychotherapie der Universitat am Bezirsklinikum, Regensburg

SOMNIBENE Institut fur Medzinische Forschung und Schlafmedizin, Schwerin

Technion Sleep Medicine Center, Rambam Medical Center, Haifa

Assuta Medical Centers, Petah Tikva

Medisch Centrum Haaglanden-Westeinde Ziekenhuis, Slaapcentrum (Holland Sleep Research), The Hague

Hospital de la Ribera, Alzira

Hospital de la Santa Crue/Sant Pau, Institut de Recerca, Barcelona

Skaraborg Hospital, Sleep Medicine Unit, Department of Neurorehabilitation, Skövde

Uppsala Akademiska Hospital, Sleep Disorder Unit, Uppsala

Psychiatric University Clinics (UPK) Basel, Dept. for Depression Research, Sleep Medicine and Neurophysiology, Basel

University Hospital Zurich (USZ), Neurology Polyclinic, Center for Sleep Medicine, Zurich

The Edinburgh Sleep Centre, Edinburgh

Medical Director, The London Sleep Centre, London

Sponsors
All Listed Sponsors
lead

Midnight Pharma, LLC

INDUSTRY